Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).

Walker JL, Wang SS, Schiffman M, Solomon D; ASCUS LSIL Triage Study Group..

Am J Obstet Gynecol. 2006 Aug;195(2):341-8.

PMID:
16890545
2.

Findings to date from the ASCUS-LSIL Triage Study (ALTS).

Schiffman M, Solomon D.

Arch Pathol Lab Med. 2003 Aug;127(8):946-9. Review.

PMID:
12873166
3.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
5.

Chapter 14: Role of triage testing in cervical cancer screening.

Solomon D.

J Natl Cancer Inst Monogr. 2003;(31):97-101. Review.

PMID:
12807952
6.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
7.

Management of cervical cytologic abnormalities.

Apgar BS, Brotzman G.

Am Fam Physician. 2004 Nov 15;70(10):1905-16. Review.

8.

Management of cervical premalignant lesions.

Lindeque BG.

Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):545-61. Review.

PMID:
16150393
9.

[Management of CIN1].

Rouzier R.

J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S114-20. doi: 10.1016/j.jgyn.2007.11.017. Review. French.

10.

[Colposcopy: the value of HPV testing in clinical practice].

Monsonego J.

Gynecol Obstet Fertil. 2004 Jan;32(1):62-74. Review. French.

PMID:
14736603
11.

HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.

Apgar BS, Brotzman G.

Am Fam Physician. 1999 May 15;59(10):2794-801. Review.

12.
13.

Human papillomavirus triage of patients with atypical squamous cells of undetermined significance on cervical Papanicolaou smear.

Kirby TO, Huh WK, Partridge EE.

Ann Acad Med Singapore. 2003 Sep;32(5):590-5; quiz 596. Review.

PMID:
14626785
14.

HPV testing: where are we now?

Bovicelli A, Bristow RE, Montz FJ.

Anticancer Res. 2000 Nov-Dec;20(6C):4673-80. Review.

PMID:
11205199
15.

Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer [Internet].

Uhlig K, Earley A, Lamont J, Dahabreh IJ, Avendano EE, Cowan JM, Feldman S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb 16.

16.

The role of human papillomavirus testing in cervical screening.

Cuschieri KS, Cubie HA.

J Clin Virol. 2005 Mar;32 Suppl 1:S34-42. Review.

PMID:
15753010
17.

What is the appropriate management for a patient with CIN1 on colposcopy?

Avrich E, Sulik S, Nashelsky J.

J Fam Pract. 2006 Feb;55(2):145-6. Review.

PMID:
16451782
19.

Testing for human papillomavirus: data driven implications for cervical neoplasia management.

Stoler MH.

Clin Lab Med. 2003 Sep;23(3):569-83, v. Review.

PMID:
14560529
20.

Human papillomavirus reporting: minimizing patient and laboratory risk.

Austin RM.

Arch Pathol Lab Med. 2003 Aug;127(8):973-7. Review.

PMID:
12873169
Items per page

Supplemental Content

Support Center